A new study has revealed that Metixene, an antiparkinsonian drug, has shown remarkable potential as a novel treatment for metastatic breast cancer and brain metastases, providing hope for patients facing this devastating ...
Oct 23, 2023
0
0
There have been incredible advances in breast cancer diagnosis and treatment in recent years. And stories about celebrities who have "beaten" breast cancer continue to be a source of inspiration for many people.
Oct 18, 2023
0
0
Despite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or Pacific Islander patients with metastatic breast cancer were less likely to receive palliative care than ...
Sep 29, 2023
0
0
Breast cancer is a heterogeneous disease, but 70% of cases are characterized by the presence of hormone receptors for estrogen, progesterone, or both. The first line of treatment for these patients, when presenting with metastatic ...
Jul 13, 2023
0
1
Metastatic breast cancer can be a daunting diagnosis, but the prognosis has improved somewhat with advances in treatment.
Jun 26, 2023
0
9
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can be used to predict early disease progression and potential survival among patients with metastatic breast cancer ...
Jun 13, 2023
0
21
A new research paper titled "Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss" has been published in Oncotarget.
Mar 14, 2023
0
2
Metastatic breast cancer has no cure and has proven stubbornly resistant to one of the most innovative and promising new cancer treatments: immunotherapy.
Mar 8, 2023
0
5
After six years of painful injections, Stephanie Walker has had enough.
Feb 8, 2023
0
4
First-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-positive]) metastatic breast cancer (MBC), ...
Dec 20, 2022
0
0
